BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/13/2026 8:28:15 AM | Browse: 1 | Download: 4
 |
Received |
|
2025-09-18 02:32 |
|
Peer-Review Started |
|
2025-09-18 02:33 |
|
First Decision by Editorial Office Director |
|
2025-11-10 07:09 |
|
Return for Revision |
|
2025-11-10 07:09 |
|
Revised |
|
2025-11-22 16:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-25 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-25 07:32 |
|
Articles in Press |
|
2025-12-25 07:32 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-26 10:35 |
|
Publish the Manuscript Online |
|
2026-03-13 08:28 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Review |
| Article Title |
Viral hepatitis after liver transplantation: A brief overview
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dibya Lochan Praharaj, Suprabhat Giri, Anil Chandra Anand, Bipadabhanjan Mallick, Preetam Nath, Saroj Kanta Sahu, Bramhadatta Pattnaik, Subrat Kumar Acharya and Yogesh Kumar Chawla |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Anil Chandra Anand, Professor, Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, KIIT Campus, Patia, Bhubaneswar 751024, Odisha, India. anilcanand@gmail.com |
| Key Words |
Viral hepatitis; Hepatotropic virus; Liver transplantation; Cytomegalovirus disease; Post-transplant lymphoproliferative disorders |
| Core Tip |
Effective management of viral hepatitis after liver transplantation hinges on early diagnosis, vigilant monitoring, and timely antiviral therapy. For hepatitis B virus, nucleos(t)ide analogues with high genetic barriers to resistance (e.g., entecavir, tenofovir alefnamide/tenofovir disoproxyl fumarate) are preferred, often with short-term hepatitis B immunoglobulin in high-risk patients. Directly acting antivirals have revolutionized treatment of patients with hepatitis C virus infection. Though timing of treatment must balance the baseline model for end stage liver disease score and graft outcomes. Hepatitis E virus infection should be suspected in unexplained graft dysfunction; ribavirin is effective when reduction of immunosupression fails. Recurrence with hepatitis D virus infection is rare if hepatitis B virus is well controlled. Infection with cytomegalovirus and Epstein-Barr virus require prophylaxis, pre-emptive monitoring, and individualized immunosuppression adjustment to reduce risk of post-transplant lymphoproliferative disorder (related to Epstein-Barr virus infection) and graft loss. |
| Publish Date |
2026-03-13 08:28 |
| Citation |
Praharaj DL, Giri S, Anand AC, Mallick B, Nath P, Sahu SK, Pattnaik B, Acharya SK, Chawla YK. Viral hepatitis after liver transplantation: A brief overview. World J Virol 2026; 15(1): 114321 |
| URL |
https://www.wjgnet.com/2220-3249/full/v15/i1/114321.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v15.i1.114321 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
